IRADIMED CORP (IRMD) — payout ratio, three ways
Fiscal year ending 2025-12-31 · sector Health care · payout ratios computed from SEC filings, not taken from a data vendor.
| Basis | Payout | Why it differs |
|---|---|---|
| GAAP earnings | 66.9% | The figure most screeners publish. |
| Operating cash flow | 60.3% | Before capital spending, so it understates the payout that free cash flow shows. |
| Free cash flow | 87.5% | What is left after maintaining the business. |
Spread between highest and lowest: 27 percentage points. Same filings, different denominators.
Coverage rating 39 / 100 — Strained. ? Peer standing 5/50Direction 30/30Stability 3/20
Free cash flow payout, last 4 years
| Fiscal year | Payout |
|---|---|
| 2025-12-31 | 87.5% |
| 2024-12-31 | 77.6% |
| 2023-12-31 | 219.5% |
| 2022-12-31 | 136.2% |
Among the 38 health care companies here, only 11% pay out a larger share on this basis — this is at the demanding end.
The arithmetic
- GAAP earnings — dividends declared per share $1.17 ÷ diluted EPS $1.75
- Operating cash flow — dividends paid $15.0m ÷ operating cash flow $24.9m
- Free cash flow — dividends paid $15.0m ÷ (operating cash flow $24.9m − capex $7.8m)
Where the figures came from
- 10-K filed 2026-03-06 · accession
0001104659-26-024691
Every one is public at sec.gov and free to check. That is the point — you should not have to take my word for any of it.
Caveats on this company
- DPS derived from dividends paid ($1.17); no per-share tag filed
Computed by an open pipeline reading SEC XBRL directly. If any number here looks wrong to you, tell me — that is more useful to me than agreement.